Bradley Paul Morgan - Net Worth and Insider Trading
Bradley Paul Morgan Net Worth
The estimated net worth of Bradley Paul Morgan is at least $2 Million dollars as of 2025-03-27. Bradley Paul Morgan is the SVP Drug Discovery & Early Dev of Cytokinetics Inc and owns about 46,441 shares of Cytokinetics Inc (CYTK) stock worth over $2 Million. Details can be seen in Bradley Paul Morgan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bradley Paul Morgan has not made any transactions after 2017-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bradley Paul Morgan
Bradley Paul Morgan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bradley Paul Morgan owns 1 companies in total, including Cytokinetics Inc (CYTK) .
Click here to see the complete history of Bradley Paul Morgan’s form 4 insider trades.
Insider Ownership Summary of Bradley Paul Morgan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTK | Cytokinetics Inc | 2017-08-31 | SVP Drug Discovery & Early Dev |
Bradley Paul Morgan Latest Holdings Summary
Bradley Paul Morgan currently owns a total of 1 stock. Bradley Paul Morgan owns 46,441 shares of Cytokinetics Inc (CYTK) as of August 31, 2017, with a value of $2 Million.
Latest Holdings of Bradley Paul Morgan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2017-08-31 | 46,441 | 43.43 | 2,016,700 |
Holding Weightings of Bradley Paul Morgan
Bradley Paul Morgan Form 4 Trading Tracker
According to the SEC Form 4 filings, Bradley Paul Morgan has made a total of 0 transactions in Cytokinetics Inc (CYTK) over the past 5 years. The most-recent trade in Cytokinetics Inc is the sale of 118,330 shares on August 31, 2017, which brought Bradley Paul Morgan around $2 Million.
Insider Trading History of Bradley Paul Morgan
- 1
Bradley Paul Morgan Trading Performance
Bradley Paul Morgan Ownership Network
Ownership Network List of Bradley Paul Morgan
Ownership Network Relation of Bradley Paul Morgan
Bradley Paul Morgan Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Bradley Paul Morgan is the SVP Drug Discovery & Early Dev of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Chief Commercial Officers Andrew Callos , and EVP & Corp. Development & CBO Robert I Blum .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Bradley Paul Morgan made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 230,315 shares made by Fady Ibraham Malik , a net sale of 326,861 shares made by Robert I Blum , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 170,428 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 170,428 shares. During the past 18 months, 709,757 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 709,757 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
Bradley Paul Morgan Mailing Address
Above is the net worth, insider trading, and ownership report for Bradley Paul Morgan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Bradley Paul Morgan's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
